Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Cash & Equivalents (2016 - 2025)

Nu-Med Plus' Cash & Equivalents history spans 11 years, with the latest figure at $11675.0 for Q4 2021.

  • On a quarterly basis, Cash & Equivalents fell 93.81% to $11675.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $11675.0, a 93.81% decrease, with the full-year FY2021 number at $11675.0, down 93.81% from a year prior.
  • Cash & Equivalents hit $11675.0 in Q4 2021 for Nu-Med Plus, down from $31840.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for NUMD hit a ceiling of $409313.0 in Q3 2017 and a floor of $6106.0 in Q2 2020.
  • Historically, Cash & Equivalents has averaged $141348.2 across 5 years, with a median of $106048.0 in 2021.
  • Biggest five-year swings in Cash & Equivalents: soared 29496.02% in 2017 and later tumbled 95.77% in 2019.
  • Tracing NUMD's Cash & Equivalents over 5 years: stood at $351043.0 in 2017, then tumbled by 52.28% to $167513.0 in 2018, then tumbled by 95.77% to $7079.0 in 2019, then soared by 2562.89% to $188506.0 in 2020, then tumbled by 93.81% to $11675.0 in 2021.
  • Business Quant data shows Cash & Equivalents for NUMD at $11675.0 in Q4 2021, $31840.0 in Q3 2021, and $72831.0 in Q2 2021.